Home
About us
Solutions
THIN
Resources
Contact
UK
Endocrinology
Home
Publications
Endocrinology
Postauthorization safety study of the DPP-4...
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.
Have any questions about our activities?
Contact us